Qyuns Therapeutics Co (HKSE:02509) Change In Working Capital : HK$0.0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Qyuns Therapeutics Co Change In Working Capital?

Qyuns Therapeutics Co's change in working capital for the quarter that ended in Dec. 2024 was HK$0.0 Mil.

Qyuns Therapeutics Co's change in working capital for the fiscal year that ended in Dec. 2024 was HK$51.3 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

Qyuns Therapeutics Co Change In Working Capital Historical Data

The historical data trend for Qyuns Therapeutics Co's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qyuns Therapeutics Co Change In Working Capital Chart

Qyuns Therapeutics Co Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Change In Working Capital

23.95

30.00

54.67

51.31

Qyuns Therapeutics Co Quarterly Data
	Dec21	Dec22	Sep23	Dec23	Jun24	Dec24
Change In Working Capital	Get a 7-Day Free Trial			-10.15	-	-	-	-

Qyuns Therapeutics Co Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.0 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

Qyuns Therapeutics Co Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Qyuns Therapeutics Co's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Qyuns Therapeutics Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qyuns Therapeutics Co Ltd (HKSE:02509) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 907 Yaocheng Avenue, Room 1310, Building 1, Taizhou, Jiangsu, CHN

Website

http://www.qyuns.net

Qyuns Therapeutics Co Ltd is a a clinical-stage biotech company focused on biologic therapies for autoimmune and allergic diseases, with a self-developed drug pipeline. It has built a pipeline that covers the four disease areas in the field, including skin, rheumatic, respiratory and digestive diseases Key revenue is generated from PRC.

Executives

Tai Zhou Yi Yao Cheng Kong Gu Ji Tuan You Xian Gong Si	2201 Interest of corporation controlled by you
Tai Zhou Jian Xin Chuang Ye Tou Zi You Xian Gong Si	2101 Beneficial owner
Hang Zhou Zhong Mei Hua Dong Zhi Yao You Xian Gong Si	2101 Beneficial owner
Zhong Guo Yuan Da Ji Tuan You Xian Ze Ren Gong Si	2201 Interest of corporation controlled by you
Tai Zhou Yi Yao Gao Xin Ji Shu Chan Ye Tou Zi Fa Zhan You Xian Gong Si	2201 Interest of corporation controlled by you
Tai Zhou Yi Yao Gao Xin Qu Hua Yin Jin Rong Tou Zi You Xian Gong Si	2201 Interest of corporation controlled by you
Bei Jing Yuan Da Hua Chuang Tou Zi You Xian Gong Si	2201 Interest of corporation controlled by you
Hua Dong Yi Yao Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you
Qiu Jiwan
Xu Qiu
Hangzhou Quanyi Investment Management Partnership (general Partnership)
Yu Guo'an
Zhu Jing
Taizhou Xinfu Tongxin Enterprise Management Partnership (limited Partnership)
Sheng Xi Tai

Qyuns Therapeutics Co Headlines

No Headlines